Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 4 3Phase 2 1

Status

Completed 5Unknown 2

Sponsor Class

OTHER 7

Study Type

Interventional 7

Sponsor

Cancer Type

Genitourinary 2Gastrointestinal 1Breast 1

Conditions

Urologic Neoplasms 2Urinary Bladder Neoplasms 1Supratentorial Brain Tumor Surgery 1Stomach Neoplasms 1Post-operative Residual Curarization 1Myasthenia Gravis 1Delayed Emergence from Anesthesia 1Breast Neoplasms 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
OTHER × Interventional × Neostigmine × Clear all
NCT06436768 2025-04-02

Efficacy and Safety of Sugammadex in Thoracoscopy Thymectomy for Chinese Adults With Myasthenia Gravis

Beijing Tongren Hospital

Phase NA Completed
62 enrolled

Myasthenia Gravis, Delayed Emergence from Anesthesia

NCT04205097 2020-12-17

Deep vs Moderate Neuromuscular Blocks on Remifentanil for Laparoscopic Gastrectomy

Ajou University School of Medicine

Phase NA Completed
120 enrolled
Gastrointestinal

Stomach Neoplasms

NCT03210376 2020-11-25

Neuromuscular Blockade on Shoulder Pain of Elderly

M.D. Anderson Cancer Center

Phase 4 Completed
100 enrolled 17 charts
Genitourinary

Urologic Neoplasms

NCT03138967 2020-09-22

Investigation of Sugammadex in Outpatient Urological Procedures

M.D. Anderson Cancer Center

Phase 4 Completed
54 enrolled 12 charts
Genitourinary

Urinary Bladder Neoplasms, Urologic Neoplasms

NCT02839668 2019-10-29

TIVA/TCI-BC

Iuliu Hatieganu University of Medicine and Pharmacy

Phase 2 Completed
120 enrolled
Breast

Breast Neoplasms

NCT03996655 2019-06-25

Different Reversal Agents in Pediatric Day-case Cancer Surgery

National Cancer Institute, Egypt

Phase 4 Unknown
80 enrolled

Post-operative Residual Curarization

NCT02944175 2018-10-19

Cerebral Oxygenation and Metabolism After Reversal Of Rocuronium: Comparison Between Sugammadex Versus Neostigmine

Mansoura University

Phase NA Unknown
40 enrolled

Supratentorial Brain Tumor Surgery

Data powered by HemOnc (CC BY 4.0) Colophon âš¡